HepQuant's Paige Nardi (VP, Market Access, Billing & Reimbursement) and Kerry Whitaker (Senior Medical Science Liaison) will be attending NAMCP’s Spring Managed Care Forum on April 24–25 at Rosen Creek,... read more →
HepQuant’s own Dr. Gregory T. Everson, CEO will present two posters at EASL Congress 2025 in Amsterdam, the Netherlands May 7 – 10. Top Poster #507 “Quantifying liver function by... read more →
Dr. Gregory T. Everson, CEO and founder of HepQuant, will discuss “Simultaneous Quantification of Native Human Liver and Porcine Liver Function in an Extracorporeal Circuit Using IV 13C-Cholate." at the upcoming... read more →
HepQuant's Dr. Joanne Imperial, Chief Medical Officer, will be attending the Global Hepatitis Summit 2025 in Los Angeles and presenting a poster titled HepQuant DuO™ for Quantifying Liver Function and... read more →
HepQuant will participate in the 5th Annual Liver Connect Conference in San Antonio, TX. A silver sponsor of the event, the HepQuant team may be found at booth 17 in... read more →
HepQuant is excited that six abstracts, will be presented, three of which were deemed a Poster of Distinction, at The Liver Meeting 2024 on 11/16/24 and 11/17/24 linked below.... read more →
